U.S. Hospitality Stock News

If you are trying to figure out whether Gold Royalty is genuinely good value or just riding hype, starting with a clear view of its current valuation is essential. Gold Royalty's share price, last seen at US$4.35, has had mixed short term moves, with a 10.3% decline over the last 7 days, a 4.3% gain over 30 days, and returns of 6.6% year to date and 191.9% over the past year. Recent commentary around Gold Royalty has focused on its position within the gold royalty space and investor interest...

If you are trying to work out whether BioStem Technologies at around US$5.95 is attractively priced or not, you are in the right place. The share price has been volatile recently, with a 51.3% gain over the last 30 days, a 22.6% decline over the last week, a 52.3% gain year to date, and a 67.1% decline over the last year, alongside very large gains over 3 and 5 years. These sharp moves have come as investors react to ongoing developments around the company and its position in the...

If you are wondering whether Lennar at around US$115 offers good value right now, or if most of the upside is already priced in, this article walks through the key numbers so you can judge for yourself. The stock has returned 4.0% over the last 7 days, 9.4% over the past 30 days and 10.6% year to date, while the 1 year return sits at an 8.0% decline and the 3 and 5 year returns are 29.3% and 43.3% respectively. Recent attention on Lennar has focused on how US housing trends and sentiment...

Why Select Medical Holdings is on investors’ radar today Select Medical Holdings (SEM) has been drawing fresh attention after recent share price moves, with the stock up about 1.4% over the past day and roughly 3.7% over the past week. See our latest analysis for Select Medical Holdings. Zooming out, the recent 1-day and 7-day share price returns sit alongside a 90-day share price return of 14.79%, while the 1-year total shareholder return is a 23.32% decline. This means short term momentum...

What the recent price move might mean for First Watch Restaurant Group (FWRG) First Watch Restaurant Group (FWRG) has drawn fresh attention after a recent share price move, with the stock closing at $17.24 and sitting on a month return of about 7% and year to date gain near 12%. See our latest analysis for First Watch Restaurant Group. Against that latest move, the 7 day share price return of 6.49% and 30 day share price return of 7.28% sit alongside a year to date share price return of...

Wondering whether IQVIA Holdings is offering good value at its current share price, or if you are better off waiting on the sidelines? This breakdown will help you frame the numbers clearly. IQVIA's share price last closed at US$202.54, with a 15.5% decline over 7 days, a 13.7% decline over 30 days and a 10.1% decline year to date, while the 1 year return shows a 1.4% decline and the 3 year return shows a 14.0% decline, compared with a 5 year return of 6.6%. Recent price moves sit against a...

Asbury Automotive Group (ABG) has just released fourth quarter and full year 2025 results, reporting higher revenue for both periods. The company also reported a sharp quarterly earnings pullback, which contrasts with improved profitability across the full year. See our latest analysis for Asbury Automotive Group. The earnings release and recent board changes arrive after a mixed period for investors, with a 4.6% 90 day share price return and a 1 year total shareholder return decline of...

Prudential Financial FY 2025 earnings snapshot Prudential Financial (PRU) has wrapped up FY 2025 with Q4 revenue of US$14.2 billion and basic EPS of US$2.56, taking trailing twelve month revenue to US$55.7 billion and EPS to US$10.05 as the shares trade around US$102.17. The company has seen quarterly revenue move from US$13.5 billion in Q1 2025 to US$17.9 billion in Q3 2025 before landing at US$14.2 billion in Q4, while basic EPS has ranged from US$1.49 to US$4.03 across the year. This gives...

Electronic Arts (EA) just posted Q3 2026 results with revenue of US$1.9b and basic EPS of US$0.35, alongside net income of US$88m, as part of a year that has seen trailing 12 month revenue of US$7.3b and EPS of US$2.70. Over the past few quarters, the company has seen revenue move between US$1.67b and US$2.03b while quarterly EPS ranged from US$0.35 to about US$1.12, giving investors plenty to think about in terms of how these headline figures are flowing through to profitability. With...

The fact that multiple Loar Holdings Inc. ( NYSE:LOAR ) insiders offloaded a considerable amount of shares over the...

Liberty Global (LBTY.A) has drawn fresh attention as investors review its recent share performance, with the stock up around 4% over the past month and about 6% in the past 3 months. See our latest analysis for Liberty Global. Beyond the recent uptick, Liberty Global’s 7 day share price return of 5.69% and 90 day share price return of 6.29% contrast with a relatively flat 0.27% total shareholder return over the past year. This suggests short term momentum has picked up even as longer term...

If you are wondering whether DraftKings' share price reflects its true worth, you are not alone, the stock has attracted a lot of attention from investors trying to work out what a fair value looks like. Recently, the stock has been under pressure, with a 9.0% decline over the last 7 days, a 22.1% decline over 30 days, and a 23.6% decline year to date, even though the 3 year return stands at 64.8%. Over the past year, DraftKings has also seen a 35.8% decline, and over 5 years the return is a...

Recent share performance and business snapshot KKR (KKR) has been on many investors’ screens after a recent stretch of weaker returns, including about a 22% decline over the past month and roughly 12% over the past 3 months. The stock closed at US$104.77, while the firm reports revenue of US$22.25b and net income of US$2.27b. Its business model is built around private equity, real estate, and a wide range of credit and infrastructure investments globally. See our latest analysis for KKR. That...

If you are wondering whether Cintas is fairly priced or if the share price has already run ahead of its value, this article will walk you through what the current market is implying and how that compares with several valuation checks. Cintas shares recently closed at US$192.61, with returns of 1.8% over the last 7 days, 3.9% over 30 days, 4.2% year to date and a 3.7% decline over the past year, alongside longer term returns of 79.9% over 3 years and 131.1% over 5 years. Recent coverage has...

BancFirst Corporation reported past fourth-quarter 2025 results with net income of US$59.5 million and higher year-over-year earnings per share, alongside net charge-offs of US$1.6 million compared with US$985,000 a year earlier. This mix of improved profitability and rising loan charge-offs highlights how BancFirst is balancing earnings strength with evolving credit costs in its loan portfolio. We’ll now examine how BancFirst’s higher net income, despite increased charge-offs, shapes its...

If you are wondering whether OneMain Holdings is priced attractively right now, it helps to line up the recent share performance with what the underlying valuation signals are saying. The stock closed at US$63.20, with returns of 20.1% over 1 year, 77.7% over 3 years and 97.9% over 5 years. This is despite the share price having seen a 2.8% decline over 7 days, a 9.9% decline over 30 days and an 8.5% decline year to date. Recent coverage has focused on how consumer credit conditions, funding...

Ionis Pharmaceuticals (NasdaqGS:IONS) received European Commission approval for Dawnzera to help prevent hereditary angioedema attacks in eligible patients. The US FDA granted Breakthrough Therapy designation to zilganersen for Alexander disease, recognizing its potential for a serious rare condition with high unmet need. Partner GSK reported positive Phase 3 results for bepirovirsen, supporting potential regulatory filings for the hepatitis B candidate. Ionis Pharmaceuticals focuses on RNA...

Flowco Holdings (NYSE:FLOC) has entered a definitive agreement to acquire the parent company of Valiant Artificial Lift Solutions. The deal expands Flowco's artificial lift portfolio and broadens its presence in production optimization technologies. Management expects the transaction to be accretive to earnings and cash flow once completed. Flowco Holdings, trading at $22.15, is coming into this deal after mixed recent share performance, with the stock up 11.8% over the past week and 16.0%...

If you are wondering whether Ventas is still reasonably priced after its recent run, this article walks through what the current share price might be implying about its value. Ventas shares last closed at US$77.73, with returns of 2.4% over the past week, 1.7% over the last month, 0.5% year to date, 31.3% over one year, 65.7% over three years and 85.8% over five years. This naturally raises questions about how much optimism is already reflected in the price. Recent coverage around Ventas has...

In January 2026, Vertiv launched Vertiv Next Predict, an AI-powered managed service that uses predictive analytics and anomaly detection to transform data center maintenance across power, cooling, and IT systems. This move deepens Vertiv’s role at the heart of AI data center infrastructure by tying its service expertise to a scalable, grid-to-chip AI operations platform designed to evolve with future technologies. We’ll now examine how this AI-driven maintenance offering could shape...

In recent sessions, ADMA Biologics reported growing analyst optimism ahead of its upcoming earnings release, supported by positive revisions to earnings estimates and recognition of its specialty focus in plasma-derived biologics for immune deficiencies and infectious diseases. An interesting angle is ADMA’s integrated plasma collection and production model, which analysts view as central to its differentiation in the biologics market. Next, we’ll explore how this rising analyst confidence...

FIGS has recently launched a Winter Olympics campaign featuring Lindsey Vonn, extending its partnership with the USOPC and outfitting Team USA’s medical team, while selling a limited-edition FIGS x Team USA collection online and in stores. By spotlighting the healthcare professionals behind an elite athlete’s comeback, FIGS is tightly aligning its brand with high-performance medicine and national pride. We’ll now examine how this high-profile Lindsey Vonn and Team USA medical team campaign...

As the United States stock market begins February on a high note, with major indices like the Dow Jones and S&P 500 showing significant gains, investors are closely monitoring opportunities amidst fluctuating economic indicators. In this environment of heightened market activity and shifting economic policies, identifying undervalued stocks can be crucial for those looking to capitalize on potential discounts in the market.

As February 2026 begins, the U.S. stock market has shown strength with major indices like the Dow Jones and S&P 500 posting significant gains, buoyed by positive economic indicators such as an unexpected expansion in manufacturing activity. In this environment of heightened market optimism, identifying high-growth tech stocks involves focusing on companies that demonstrate robust innovation and adaptability to capitalize on emerging trends and technological advancements.